CN101322794A - Medicine for treating osteonosus - Google Patents
Medicine for treating osteonosus Download PDFInfo
- Publication number
- CN101322794A CN101322794A CNA200810136802XA CN200810136802A CN101322794A CN 101322794 A CN101322794 A CN 101322794A CN A200810136802X A CNA200810136802X A CN A200810136802XA CN 200810136802 A CN200810136802 A CN 200810136802A CN 101322794 A CN101322794 A CN 101322794A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- treatment
- osteopathia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating osteopathy. The purpose of the invention is to solve the problem that most existing medicines for treating cervical spondylopathy, fermoral head necrosis and lumbar intervertebral disc protrusion are just that a medicine aims at curing one disease rather than a plurality of diseases. The medicine is made from the following materials with the weight proportion by parts: 10-20 parts of red ginseng, 10-20 parts of frankincense, 10-20 parts of myrrh, 10-20 parts of panax pseudoginseng, 10-20 parts of resina draconis, 10-20 parts of safflower, 10-20 parts of thoqqua, 10-20 parts of earthworm, 10-20 parts of dipsacus root, 1-3 parts of musk, 10-20 parts of angelica, 10-20 parts of salvia miltiorrhiza, 2-4 parts of centipede, 10-20 parts of pangolin and 10-20 parts of pyrite. Clinical trials prove that the medicine of the invention has better curative effect on symptoms of cervical spondylopathy, fermoral head necrosis and lumbar intervertebral disc protrusion, and has the advantages of reasonable formula, quick action, less pain for patients during treatment, reliable curative effect, and simultaneous treatment of a plurality of diseases as well as no toxic and side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of osteopathia.
Background technology
Cervical spondylosis, femur head necrosis and prolapse of lumbar intervertebral disc (being called " prolapse of lumbar intervertebral disc " traditionally) disease is the big persistent ailment of three in the osteopathia, the health of serious harm human body.It is many to have the medicament categories that is used for the treatment of cervical spondylosis, femur head necrosis and prolapse of lumbar intervertebral disc now, but said medicine is a kind of disease of a kind of Drug therapy mostly, medicine such as the treatment cervical spondylosis can not be treated femur head necrosis or prolapse of lumbar intervertebral disc, and the medicine of treatment femur head necrosis can not be treated prolapse of lumbar intervertebral disc or cervical spondylosis.Some patient not only suffers from cervical spondylosis but also suffer from prolapse of lumbar intervertebral disc, perhaps not only suffer from femur head necrosis disease but also suffer from cervical spondylosis, will take two kinds of medicines simultaneously at this time, not only financial burden is heavier to take two kinds of medicines simultaneously, also might two kinds in the medicine some compositions restriction or checking relation in five elements and lessen the curative effect or produce noxious substance, for avoiding the appearance of the problems referred to above, the doctor often advises treatment a kind of disease wherein earlier, treat that this disease takes a turn for the better or stable after consider wherein another kind of sick of treatment again.Like this certainly will the extended treatment time, very unfavorable to patient's physical and mental health.
Summary of the invention
The objective of the invention is for solving the existing medicament categories that is used for the treatment of cervical spondylosis, femur head necrosis and prolapse of lumbar intervertebral disc often, but said medicine is a kind of disease of a kind of Drug therapy mostly, and problem that can not medicine Zhiduo County disease provides a kind of medicine for the treatment of osteopathia.A kind of medicine for the treatment of osteopathia of the present invention is made for 10～20 parts by 10～20 parts of Radix Ginseng Rubra (Radix Ginseng), 10～20 parts of Olibanums, 10～20 parts of Myrrhas, 10～20 parts of Radix Notoginseng, 10～20 parts of Sanguis Draxonis, 10～20 parts on Flos Carthami, 10～20 parts of eupolyphage sece steleophagas, 10～20 parts of Pheretimas, 10～20 parts of Radix Dipsaci, 1～3 part in Moschus, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Salviae Miltiorrhizaes, 2～4 parts of Scolopendras, 10～20 parts of Squama Maniss and Pyritum by weight.A kind of its manufacture method of medicine for the treatment of osteopathia is: by weight 10～20 parts of Radix Ginseng Rubra, 10～20 parts of Olibanums, 10～20 parts of Myrrhas, 10～20 parts of Radix Notoginseng, 10～20 parts of Sanguis Draxonis, 10～20 parts on Flos Carthami, 10～20 parts of eupolyphage sece steleophagas, 10～20 parts of Pheretimas, 10～20 parts of Radix Dipsaci, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Salviae Miltiorrhizaes, 2～4 parts of Scolopendras, 10～20 parts of Squama Maniss and Pyritum are ground into 80～200 purpose powder for 10～20 parts, then 1～3 part Moschus is incorporated in the described powder and stirs, the powder that stirs is incapsulated, each capsule pack into 0.2 the gram.
A kind of medicine pharmaceutical test summary for the treatment of osteopathia of the present invention:
One, clinical data:
Case is selected:
Select 30 routine patients at random at hospital outpatient, male's 21 examples wherein, women's 9 examples, at minimum 35 years old of age, maximum 58 years old, 46 years old mean age, the course of disease is the shortest 6 months, and was the longest 7 years.
Wherein 15 people suffer from cervical spondylosis and two kinds of diseases of femur head necrosis disease, and 12 people suffer from prolapse of lumbar intervertebral disc and two kinds of diseases of cervical spondylosis, and 3 people suffer from cervical spondylosis, femur head necrosis and three kinds of diseases of prolapse of lumbar intervertebral disc.
Two, the diagnostic criteria of disease:
1, cervical spondylosis: cervical spondylosis is because the syndrome of degeneration of cervical intervertebral disc, the caused a series of clinical symptoms of hyperosteogeny of cervical vertebra.Cervical spondylosis can be divided into neck type, spondylotic radiculopathy, myeloid form, vertebral artery type, adrenergic type and its alloytype, and clinical often showing as on neck, shoulder arm, the omoplate carried on the back and anterior pectorial region pain arm numbness of hand wood, amyotrophy, even quadriplegia.
2, femur head necrosis disease: femur head necrosis full name aseptic necrosis of femoral head or ischemic necrosis of femoral head, be that the local blood fortune of femoral head that causes owing to multiple reason is bad, thereby cause a kind of pathological changes of the further ischemia of osteocyte, necrosis, bone trabecula fracture, collapse of the femoral head.Beginning shows as hip joint or its dull pain, the dull pain in joint on every side more, and the activity postemphasis further develops the dysfunction that can cause hip joint, has a strong impact on patient's quality of life and work capacity.
3, prolapse of lumbar intervertebral disc: intervertebral disc prolapse is a frequently-occurring disease, commonly encountered diseases, it mainly because of intervertebral disc strain degeneration, fibrous ring is broken or vertebral pulp is deviate from etc., stimulate or a series of syndromes that compressing spinal nerves, spinal cord etc. cause.Adult's intervertebral disc generation degenerative change, the fibre thickening in the fibrous ring becomes fragile so that eventual failure, makes intervertebral disc lose original elasticity, can not undertake the pressure of bearing originally.In excessive strain, the position cataclysm, with sudden force action or violence bump down, fibrous ring can outside bulging, thus vertebral pulp also can be outwards outstanding through the crack of disruptive fibrous ring, Here it is so-called intervertebral disk hernia.Prolapse of lumbar intervertebral disc causes waist distending pain, sciatic nerve radiating pain, the numbness of lower limbs distending pain, feel to go down or hyperalgesia, amyotrophy, trouble lower limb attenuate, difficulty in walking etc., fecal and urinary functions obstacle, lower extremity paralysis, long-term bed do not rise and make patient's Disability that descends quality of life, works when serious.
Three, the contained composition of medication: promptly by aforementioned 15 (ten thousand bone spirits) capsules of making of flavor Chinese medicines, 0.2 grammes per square metre/every capsule.
Four, administrated method: each oral 1 gram (5 capsules), day clothes three times, ante cibum, one after each meal all can, warm water delivery service, 28 days one courses of treatment.
Five, the criterion of curative effect: (after the course of treatment)
1, recovery from illness: waist, hip, lower limb, cervical vertebra ache and sign disappear, can normal activity.
2, produce effects: pain and sign are clearly better, and be movable normal.
3, effective: pain and sign turn for the better by and large, and activity is restricted slightly.
4, invalid: symptom and sign do not change.
Six, efficacy result analysis:
| Case | The example number | Recovery from illness (%) | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| 30 | 17(56.7) | 7(23.3) | 4(13.3) | 2(6.7) | 93.3 |
A kind of medicine of osteopathia for the treatment of of the present invention is through clinical experiment, discovery also has certain curative effect to the difficult bone injury osteopathia pertinacious diseases such as joint stiffness, bone regeneration (bony spur), osteoporosis, meniscus injury, condensing osteitis, patella osteomalacia disease, osteochondritis (developmental character pain) and all kinds of athletic injury of bone injury sequela, and does not find toxic and side effects.
Medicine of the present invention is through clinical trial, its result shows, it all has better curative effect to diseases such as cervical spondylosis, femur head necrosis and prolapse of lumbar intervertebral disc, and how disease is ruled together, and has the advantage that patient's misery less during reasonable recipe, instant effect, the treatment, curative effect is reliable, cure rate is high, have no side effect.
The specific embodiment
The specific embodiment one: a kind of medicine for the treatment of osteopathia of present embodiment is made for 10～20 parts by 10～20 parts of Radix Ginseng Rubra (Radix Ginseng), 10～20 parts of Olibanums, 10～20 parts of Myrrhas, 10～20 parts of Radix Notoginseng, 10～20 parts of Sanguis Draxonis, 10～20 parts on Flos Carthami, 10～20 parts of eupolyphage sece steleophagas, 10～20 parts of Pheretimas, 10～20 parts of Radix Dipsaci, 1～3 part in Moschus, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Salviae Miltiorrhizaes, 2～4 parts of Scolopendras, 10～20 parts of Squama Maniss and Pyritum by weight.
The specific embodiment two: a kind of medicine for the treatment of osteopathia of present embodiment is made for 11～19 parts by 11～19 parts of Radix Ginseng Rubra, 11～19 parts of Olibanums, 11～19 parts of Myrrhas, 11～19 parts of Radix Notoginseng, 11～19 parts of Sanguis Draxonis, 11～19 parts on Flos Carthami, 11～19 parts of eupolyphage sece steleophagas, 11～19 parts of Pheretimas, 11～19 parts of Radix Dipsaci, 1.2～2.5 parts in Moschus, 11～19 parts of Radix Angelicae Sinensis, 11～19 parts of Radix Salviae Miltiorrhizaes, 2.5～3.5 parts of Scolopendras, 11～19 parts of Squama Maniss and Pyritum by weight.
The specific embodiment three: a kind of medicine for the treatment of osteopathia of present embodiment is made for 12～18 parts by 12～18 parts of Radix Ginseng Rubra, 12～18 parts of Olibanums, 12～18 parts of Myrrhas, 12～18 parts of Radix Notoginseng, 12～18 parts of Sanguis Draxonis, 12～18 parts on Flos Carthami, 12～18 parts of eupolyphage sece steleophagas, 12～18 parts of Pheretimas, 12～18 parts of Radix Dipsaci, 1.3～2.3 parts in Moschus, 12～18 parts of Radix Angelicae Sinensis, 12～18 parts of Radix Salviae Miltiorrhizaes, 2.7～3.2 parts of Scolopendras, 12～18 parts of Squama Maniss and Pyritum by weight.
The specific embodiment four: a kind of medicine for the treatment of osteopathia of present embodiment is made for 15 parts by 15 parts of Radix Ginseng Rubra, 15 parts of Olibanums, 15 parts of Myrrhas, 15 parts of Radix Notoginseng, 15 parts of Sanguis Draxonis, 15 parts on Flos Carthami, 15 parts of eupolyphage sece steleophagas, 15 parts of Pheretimas, 15 parts of Radix Dipsaci, 1.4 parts in Moschus, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Salviae Miltiorrhizaes, 2.9 parts of Scolopendras, 15 parts of Squama Maniss and Pyritum by weight.
Claims (4)
1, a kind of medicine for the treatment of osteopathia is characterized in that: a kind of medicine for the treatment of osteopathia is made for 10～20 parts by 10～20 parts of Radix Ginseng Rubra, 10～20 parts of Olibanums, 10～20 parts of Myrrhas, 10～20 parts of Radix Notoginseng, 10～20 parts of Sanguis Draxonis, 10～20 parts on Flos Carthami, 10～20 parts of eupolyphage sece steleophagas, 10～20 parts of Pheretimas, 10～20 parts of Radix Dipsaci, 1～3 part in Moschus, 10～20 parts of Radix Angelicae Sinensis, 10～20 parts of Radix Salviae Miltiorrhizaes, 2～4 parts of Scolopendras, 10～20 parts of Squama Maniss and Pyritum by weight.
2, a kind of medicine for the treatment of osteopathia according to claim 1 is characterized in that: a kind of medicine for the treatment of osteopathia is made for 11～19 parts by 11～19 parts of Radix Ginseng Rubra, 11～19 parts of Olibanums, 11～19 parts of Myrrhas, 11～19 parts of Radix Notoginseng, 11～19 parts of Sanguis Draxonis, 11～19 parts on Flos Carthami, 11～19 parts of eupolyphage sece steleophagas, 11～19 parts of Pheretimas, 11～19 parts of Radix Dipsaci, 1.2～2.5 parts in Moschus, 11～19 parts of Radix Angelicae Sinensis, 11～19 parts of Radix Salviae Miltiorrhizaes, 2.5～3.5 parts of Scolopendras, 11～19 parts of Squama Maniss and Pyritum by weight.
3, a kind of medicine for the treatment of osteopathia according to claim 1 is characterized in that: a kind of medicine for the treatment of osteopathia is made for 12～18 parts by 12～18 parts of Radix Ginseng Rubra, 12～18 parts of Olibanums, 12～18 parts of Myrrhas, 12～18 parts of Radix Notoginseng, 12～18 parts of Sanguis Draxonis, 12～18 parts on Flos Carthami, 12～18 parts of eupolyphage sece steleophagas, 12～18 parts of Pheretimas, 12～18 parts of Radix Dipsaci, 1.3～2.3 parts in Moschus, 12～18 parts of Radix Angelicae Sinensis, 12～18 parts of Radix Salviae Miltiorrhizaes, 2.7～3.2 parts of Scolopendras, 12～18 parts of Squama Maniss and Pyritum by weight.
4, a kind of medicine for the treatment of osteopathia according to claim 1 is characterized in that: a kind of medicine for the treatment of osteopathia is made for 15 parts by 15 parts of Radix Ginseng Rubra, 15 parts of Olibanums, 15 parts of Myrrhas, 15 parts of Radix Notoginseng, 15 parts of Sanguis Draxonis, 15 parts on Flos Carthami, 15 parts of eupolyphage sece steleophagas, 15 parts of Pheretimas, 15 parts of Radix Dipsaci, 1.4 parts in Moschus, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Salviae Miltiorrhizaes, 2.9 parts of Scolopendras, 15 parts of Squama Maniss and Pyritum by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810136802XA CN101322794B (en) | 2008-07-28 | 2008-07-28 | Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810136802XA CN101322794B (en) | 2008-07-28 | 2008-07-28 | Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101322794A true CN101322794A (en) | 2008-12-17 |
| CN101322794B CN101322794B (en) | 2010-12-29 |
Family
ID=40186595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810136802XA Expired - Fee Related CN101322794B (en) | 2008-07-28 | 2008-07-28 | Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101322794B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405661A (en) * | 2013-08-12 | 2013-11-27 | 崔令久 | Formula for treatment of diseases about fracture, bone fracture, calcium supplement and osteoporosis and preparation method |
| CN104257967A (en) * | 2014-09-30 | 2015-01-07 | 山东师范大学 | Traditional Chinese medicine for treating sports injury |
| CN112168548A (en) * | 2020-10-22 | 2021-01-05 | 王燕铭 | Treatment bed for femoral neck fracture |
| CN113813324A (en) * | 2020-06-17 | 2021-12-21 | 北京圣手苗医堂企业管理有限公司 | A Chinese medicinal composition for treating osteoporosis and femoral head necrosis, and its preparation method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1065132C (en) * | 1997-03-07 | 2001-05-02 | 崔庆杰 | Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc |
| CN1333025A (en) * | 2000-07-11 | 2002-01-30 | 李鹏 | Medicine for treating bone injury |
-
2008
- 2008-07-28 CN CN200810136802XA patent/CN101322794B/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405661A (en) * | 2013-08-12 | 2013-11-27 | 崔令久 | Formula for treatment of diseases about fracture, bone fracture, calcium supplement and osteoporosis and preparation method |
| CN104257967A (en) * | 2014-09-30 | 2015-01-07 | 山东师范大学 | Traditional Chinese medicine for treating sports injury |
| CN104257967B (en) * | 2014-09-30 | 2017-08-29 | 山东师范大学 | A kind of Chinese medicine for treating injury gained in sports |
| CN113813324A (en) * | 2020-06-17 | 2021-12-21 | 北京圣手苗医堂企业管理有限公司 | A Chinese medicinal composition for treating osteoporosis and femoral head necrosis, and its preparation method |
| CN112168548A (en) * | 2020-10-22 | 2021-01-05 | 王燕铭 | Treatment bed for femoral neck fracture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101322794B (en) | 2010-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181453B (en) | Chinese medicine preparation for curing orthopaedics sickness | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN105982976B (en) | Treat bone penetrating fluid of bone and joint diseases and preparation method thereof | |
| CN101322794B (en) | Medicine for treating cervical spondylosis, ANFH and Lumbar Disc Herniation | |
| CN1539479A (en) | Drug for curing disease of proplapse of lumbar intervertebral disc | |
| CN104758659A (en) | Traditional Chinese medicine paste for treating muscle and bone diseases | |
| CN102441145B (en) | Medicament for treating lumbar disc herniation and cervical spondylosis | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN101433647B (en) | Plaster for treating femoral head necrosis and preparation method thereof | |
| CN103446360A (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
| CN106177002A (en) | A kind of medicated powder medicated wine complex treating bone matrix hyperplasia | |
| CN1970067B (en) | Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis | |
| CN102008666B (en) | Drug for treating lumbocrural pain | |
| CN105687944A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis | |
| CN105395867A (en) | Traditional Chinese medicine bone-joining elixir for treating fracture and preparation method of traditional Chinese medicine bone-joining elixir | |
| CN100369619C (en) | Chinese medicine preparation for treating femoral head necrosis | |
| CN101249187B (en) | Chinese medicine for curing neck protrusion of lumbar vertebral disc | |
| CN103961655A (en) | Medicament for treating femoral head necrosis and preparation method thereof | |
| CN102283942A (en) | Orally-administrated Chinese medicinal preparation for treating ankylosing spondlitis | |
| CN106620110A (en) | Medicinal liquor for treating bone diseases | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN102784360B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spine bone hyperplasia | |
| CN101744901B (en) | Medicinal pillow for treating cervical spondylosis | |
| CN101690792B (en) | Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc | |
| CN105031060A (en) | Traditional Chinese medicine preparation for treating orthopedic disease and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101229 Termination date: 20120728 |